Page 39 - Assurance of Sterility for Sensitive Combination Products and Materials
P. 39

Terminal sterilization   27


              in the 1990s. Both moist and dry heat rely on the same fundamental mech-
              anism to inactivate microorganisms. The thermal energy results in the de-
              naturation of proteins and enzymes. This loss of functionality of enzymes
              causes the death of the organism. The difference in the efficiency between
              dry and moist heat arises from the difference in efficiency with which the
              thermal energy is transmitted to the organism. In dry heat, the energy is
              transmitted by the conduction of heat through air. This is relatively ineffi-
              cient. Moist heat sterilizations rely on the high latent heat of vaporization
              to efficiently transfer heat from the steam to the microbes to affect the kill.
              As the saturated steam interacts with the surface, it condenses, transferring
              the heat to the surface. The change in phase from gas to liquid also results
              in a reduction in volume which in turn draws more gas to the surface. This
              process continues until the surface equilibrates in temperature with the
              steam. As this energy interacts with the organism, it rapidly raises the tem-
              perature of the cell. This denatures the proteins, enzymes, and DNA. The
              denaturation of the enzymes results in the loss of function and death of the
              organism. Key factors which govern both dry and moist heat sterilization
              are as follows:




              Factor                Dry                   Moist
              Barriers              Thermal               Thermal and tortuosity
                                                            path
              Temperature           Of oven               Of Steam
              Pressure              No                    Yes
              Time                  Yes                   Yes



              3.2  Sterile validation of current methods

              The risk of non-sterile product reaching the patient is extremely low, but
              the criticality is high because many of the device combination products are
              parenteral or implantable. Even if the probability of the event happening is
              very low, the impact can be catastrophic. The paradox for sterility testing
              is that the low incident rate and the destructive nature of the testing make
              the verification strategies impractical. The validation of a terminal steril-
              ization process requires qualification of the product, the equipment, and
              the process. The definition of packaging constraints, microbial quantity, and
              quality of the product are all needed to meet the rigor of validation. In con-
              trast to aseptic processing, the validation of the terminal sterilization process
   34   35   36   37   38   39   40   41   42   43   44